Starpharma Holdings (ASX:SPL) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings Short-Term Capital Lease Obligation?

Starpharma Holdings's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Starpharma Holdings's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.74 Mil) but then declined from Jun. 2023 (A$0.74 Mil) to Dec. 2023 (A$0.00 Mil).

Starpharma Holdings's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (A$0.69 Mil) to Jun. 2022 (A$0.70 Mil) and increased from Jun. 2022 (A$0.70 Mil) to Jun. 2023 (A$0.74 Mil).

Starpharma Holdings Short-Term Capital Lease Obligation Historical Data

The historical data trend for Starpharma Holdings's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Short-Term Capital Lease Obligation Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.03

0.60

0.69

0.70

0.74

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	0.70	-	0.74	-

Starpharma Holdings Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Starpharma Holdings Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (ASX:SPL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings (ASX:SPL) Headlines

No Headlines